OPF-310
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OPF-310, covering 2026-03-02 to 2026-03-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus [Phase 1, Phase 2]